S Shack

537 total citations
8 papers, 491 citations indexed

About

S Shack is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, S Shack has authored 8 papers receiving a total of 491 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in S Shack's work include Cancer, Lipids, and Metabolism (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). S Shack is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers) and Drug Transport and Resistance Mechanisms (2 papers). S Shack collaborates with scholars based in United States. S Shack's co-authors include Dvorit Samid, Charles E. Myers, W. Robert Hudgins, Lei Liu, Edward H. Oldfield, Zvi Ram, Stuart Walbridge, P Prasanna, Alain Thibault and Aaron B. Miller and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Clinical Cancer Research.

In The Last Decade

S Shack

8 papers receiving 473 citations

Peers

S Shack

MB

CR

ONCOL

GENET

CB

Yelena Zabelina United States

Rogier W. Rooswinkel Netherlands

Peggy L. Young United States

Kunihiko Tatsumi Japan

Hyeong‐Reh Choi Kim United States

Zofia M. Kiliańska Poland

Dmitri Dvorzhinski United States

Ekta Agarwal United States

Marike W. van Gisbergen Netherlands

Yelena Zabelina United States

S Shack

485 ×1.6

MB

63 ×0.3

CR

223 ×1.5

ONCOL

45 ×0.7

GENET

14 ×0.3

CB

Citations per year, relative to S Shack S Shack (= 1×) peers Yelena Zabelina

Countries citing papers authored by S Shack

Since Specialization

Citations

This map shows the geographic impact of S Shack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Shack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Shack more than expected).

Fields of papers citing papers by S Shack

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Shack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Shack. The network helps show where S Shack may publish in the future.

Co-authorship network of co-authors of S Shack

This figure shows the co-authorship network connecting the top 25 collaborators of S Shack. A scholar is included among the top collaborators of S Shack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Shack. S Shack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Borad, Mitesh J., Robert Penny, Michael Bittner, et al.. (2006). Molecular profiling using immunohistochemistry (IHC) and DNA microarray (DMA) as a tool to determine potential therapeutic targets in patients who have progressed on multiple prior therapies. Clinical Cancer Research. 12. 4 indexed citations

2.

Hoff, Daniel D. Von, Robert Penny, S Shack, et al.. (2006). Frequency of potential therapeutic targets identified by immunohistochemistry (IHC) and DNA microarray (DMA) in tumors from patients who have progressed on multiple therapeutic agents. Journal of Clinical Oncology. 24(18_suppl). 3071–3071. 15 indexed citations

3.

Samid, Dvorit, et al.. (1997). Phenylacetate and Phenylbutyrate as Novel, Nontoxic Differentiation Inducers. Advances in experimental medicine and biology. 400A. 501–505. 54 indexed citations

4.

Shack, S, Aaron B. Miller, Lei Liu, et al.. (1996). Vulnerability of multidrug-resistant tumor cells to the aromatic fatty acids phenylacetate and phenylbutyrate.. PubMed. 2(5). 865–72. 27 indexed citations

5.

Samid, Dvorit, Zvi Ram, W. Robert Hudgins, et al.. (1994). Selective activity of phenylacetate against malignant gliomas: resemblance to fetal brain damage in phenylketonuria.. PubMed. 54(4). 891–5. 99 indexed citations

6.

Ram, Zvi, Stuart Walbridge, Eric M. Oshiro, et al.. (1994). Growth inhibition, tumor maturation, and extended survival in experimental brain tumors in rats treated with phenylacetate.. PubMed. 54(11). 2923–7. 41 indexed citations

7.

Shack, S, et al.. (1993). Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate.. Journal of Clinical Investigation. 91(5). 2288–2295. 121 indexed citations

8.

Samid, Dvorit, et al.. (1992). Phenylacetate: a novel nontoxic inducer of tumor cell differentiation.. PubMed. 52(7). 1988–92. 130 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact